ALDH6A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.83010000049033E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.38719999995563E-07 |
Normal-vs-Stage2 |
1.13479999996891E-06 |
Normal-vs-Stage3 |
3.08579999996894E-07 |
Normal-vs-Stage4 |
1.59359999973852E-07 |
Stage1-vs-Stage2 |
5.323400E-01 |
Stage1-vs-Stage3 |
5.069000E-01 |
Stage1-vs-Stage4 |
2.794600E-01 |
Stage2-vs-Stage3 |
3.779600E-01 |
Stage2-vs-Stage4 |
1.615990E-01 |
Stage3-vs-Stage4 |
3.496800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.22860000015568E-07 |
Normal-vs-AfricanAmerican |
2.67999999969959E-07 |
Normal-vs-Asian |
1.02250000000303E-06 |
Caucasian-vs-AfricanAmerican |
1.306390E-01 |
Caucasian-vs-Asian |
8.261200E-01 |
AfricanAmerican-vs-Asian |
8.959800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.59429999985394E-07 |
Normal-vs-Female |
4.62130000045136E-07 |
Male-vs-Female |
5.222800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.1399000000043E-07 |
Normal-vs-Extreme_Weight |
2.3544000005149E-07 |
Normal-vs-Obese |
3.54340000008335E-07 |
Normal-vs-Extreme_Obese |
1.32710000000369E-06 |
Normal_Weight-vs-Extreme_Weight |
5.155800E-01 |
Normal_Weight-vs-Obese |
6.485400E-01 |
Normal_Weight-vs-Extreme_Obese |
3.230800E-01 |
Extreme_Weight-vs-Obese |
2.829600E-01 |
Extreme_Weight-vs-Extreme_Obese |
2.280200E-01 |
Obese-vs-Extreme_Obese |
3.668800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.18179999955659E-07 |
Normal-vs-Age(41-60Yrs) |
2.95660000038112E-07 |
Normal-vs-Age(61-80Yrs) |
4.98819999972255E-07 |
Normal-vs-Age(81-100Yrs) |
1.04119999999597E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.410600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.368360E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.816200E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.669620E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.152750E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.074800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.88530000003284E-07 |
Normal-VS-Type2 PRCC |
1.2040000000324E-06 |
Normal-VS-KIRP CIMP |
1.03960000052972E-07 |
Normal-VS-Unclassified PRCC |
3.69310000025713E-07 |
Type1 PRCC-VS-Type2 PRCC |
3.841900E-03 |
Type1 PRCC-VS-KIRP CIMP |
1.282150E-03 |
Type1 PRCC-VS-Unclassified PRCC |
5.981400E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.26960000002008E-06 |
Type2 PRCC-VS-Unclassified PRCC |
1.126610E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.533900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.59419999990318E-07 |
Normal-vs-N1 |
2.76770000029458E-07 |
Normal-vs-N2 |
6.71430000487305E-08 |
N0-vs-N1 |
2.412600E-01 |
N0-vs-N2 |
2.155600E-04 |
N1-vs-N2 |
1.482920E-03 |
|
|